Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry

Previous work demonstrated that serum metabolomics can distinguish pancreatic cancer from benign disease. However, in the clinic, non-pancreatic periampullary cancers are difficult to distinguish from pancreatic cancer. Therefore, to test the clinical utility of this technology, we determined whethe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Metabolites
Autori principali: McConnell, Yarrow J., Farshidfar, Farshad, Weljie, Aalim M., Kopciuk, Karen A., Dixon, Elijah, Ball, Chad G., Sutherland, Francis R., Vogel, Hans J., Bathe, Oliver F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372206/
https://ncbi.nlm.nih.gov/pubmed/28098776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo7010003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi